Pressrelease: InfiCure Bio secures US patent and publishes new data in a top scientific journal

https://www.mynewsdesk.com/se/umeaa-biotech-incubator/pressreleases/inficure-bio-secures-us-patent-and-publishes-new-data-in-a-top-scientific-journal-3060618?utm_source=rss&utm_medium=rss&utm_campaign=Alert&utm_content=pressrelease

Pressrelease: InfiCure Bio secures US patent and publishes new data in a top scientific journal2020-12-21T11:30:26+01:00

New publication on the liver phenotype of the NIF mouse

Check out our new exciting study describing the liver phenotype of the NIF mouse! We are proud to announce that it has been accepted for publication in Scientific Reports (https://lnkd.in/emhf8h7). In this paper we demonstrate that the transgenic NKT cells drive a type 1 inflammatory response involving the activation of the NLRP3 inflammasome and promote [...]

New publication on the liver phenotype of the NIF mouse2020-12-11T15:17:47+01:00

InfiCure Bio will attend the annual NASH Summit in mid December

InfiCure Bio AB will attend the 4th NASH Summit (https://nash-summit.com) in mid December and our CEO Sofia Mayans will give a talk on our unique NIF mouse on December 16th at 2.45pm EST. Do not miss this opportunity to talk to us about how you can use our NIF mouse to make progress in your [...]

InfiCure Bio will attend the annual NASH Summit in mid December2020-12-08T13:51:58+01:00
Go to Top